Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2017-02-27 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT POSITIVE DRIVER FROM NEW VERSION OF NRDL
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Uni-Bio Science Group Limited regarding the positive impact of the new version of the National Reimbursement Drug List on two of its core products. It discusses product details, market potential, and expected sales growth. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an announcement of business developments related to product reimbursement status, not a formal financial report or regulatory filing. It is not an earnings release, annual report, or interim report. The document is also not a regulatory filing or certification. Given the content and length (5157 characters), it fits best as a general regulatory announcement about business developments, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other categories.
2017-02-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 January 2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements and related securities information to the exchange. It does not contain financial statements or earnings data, nor is it an announcement of a report publication. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2017-02-03 English
CHANGE IN SHAREHOLDING
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a change in shareholding structure involving key shareholders and family trusts. It references specific shareholding percentages before and after the transaction and mentions compliance with Listing Rules and Inside Information Provisions. There is no financial data, earnings information, or detailed report content. The document is not a full financial report, earnings release, or management discussion. It is a notification of changes in significant share ownership levels, fitting the definition of a Major Shareholding Notification (MRQ). The document length and content confirm it is not a brief report publication announcement or regulatory filing fallback. Therefore, the classification is MRQ with high confidence.
2017-01-20 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including committees such as the Audit Committee, Remuneration Committee, and Nomination Committee. It is dated and provides details about the board composition effective from a specific date. There is no financial data, no report content, no voting results, no announcements of report publication, or other regulatory filings. The content is focused on the board and management structure. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and purely informational about board members, which aligns with MANG rather than other categories.
2017-01-13 English
(1) CHANGES OF EXECUTIVE DIRECTOR, CHAIRMAN OF THE BOARD, AUTHORISED REPRESENTATIVE AND COMPOSITION OF BOARD COMMITTEES&#x3b; AND (2) CONNECTED TRANSACTION: ISSUE OF SERVICE SHARES UNDER SPECIFIC
Board/Management Information Classification · 95% confidence The document is an announcement from a company listed on the Hong Kong Stock Exchange regarding changes in the board of directors and senior management positions, including the retirement of an executive director and the appointment of new executive directors and chairman. It also discusses connected transactions related to the issuance of service shares under a specific mandate, which requires shareholder approval. The content focuses on management changes and related governance matters rather than financial results, audit, or other report types. There is no indication that this is a full annual or interim report, earnings release, or any other financial report. The document is clearly about board and management changes and related corporate governance disclosures. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence in this classification.
2017-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2016
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 December 2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. This fits the category of Share Issue/Capital Change (SHA) as it reports on share capital changes and share issuance activities.
2017-01-03 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.